Amazon Is Headed for the Prescription-Drug Market, Analysts Say
- CVS and Walgreens would be most threatened by online giant
- Amazon could buy mid-sized drug benefit manager: analyst
How Jeff Bezos Became the King of E-Commerce
This article is for subscribers only.
Amazon.com Inc. is almost certain to enter the business of selling prescription drugs by 2019, said two analysts at Leerink Partners, posing a direct threat to the U.S.’s biggest brick-and-mortar drugstore chains.
“It’s a matter of when, not if,” Leerink Partners analyst David Larsen said in a report to clients late Thursday. “We expect an announcement within the next 1-2 years.”